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Abstract 
Kaposi’s sarcoma is an uncommon endothelial malignant tumor, first described by Moricz 
Kaposi in 1872. It is commonly encountered in patients with acquired immunodeficiency 
syndrome (AIDS), immunosuppression or organ transplantation. Conjunctival Kaposi’s 
sarcoma is a rare tumor, mostly in patients with AIDS. We present a selected case with a 
superior bulbar conjunctival lesion in a patient who is HIV negative and 
immunocompetent, with an unremarkable general medical history. The lesion was 
surgically excised with no adjunctive treatment, and histological examination confirmed 
the diagnosis. There was no recurrence or metastasis 5 years after surgery. 
Introduction 
Kaposi’s sarcoma (KS) is an uncommon spindle cell malignancy of endothelial cell 
origin, first described by Moricz Kaposi in 1872. It is frequently encountered in patients 
with acquired immunodeficiency syndrome (AIDS), immunosuppression, organ 
transplantation or human herpes simplex virus-8 (HHV-8) infection [1–3]. Conjunctival 
sarcoma is rare and is encountered mostly in patients with AIDS, in some cases as the first 
clinical presentation [4, 5]. We report a case of an immunocompetent patient with a 
superior bulbar conjunctival KS, managed successfully with surgical excision alone. Case Rep Ophthalmol 2011;2:193–197 
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A 70-year-old male presented with a 3-month history of a gradually growing mass on his left 
superior bulbar conjunctiva (fig. 1a). Examination revealed a dark red, firm, painless mass with a 
thinner stalk attachment on the conjunctiva and no evidence of orbital or scleral invasion (fig. 1b). This 
was an isolated ocular involvement in a HIV-negative patient, with no clinical evidence of 
immunosuppression and unremarkable general health. 
We applied our standard protocol for a potentially malignant conjunctival lesion. Surgical excision 
included a 2-mm margin of healthy tissue around the conjunctival stalk and the underlying Tenon’s 
capsule followed by meticulous hemostasis with a bipolar cautery. Additional intervention like 
cryotherapy or radiotherapy was reserved for a possible incomplete excision depending on the 
histological diagnosis. The bare sclera defect was allowed to granulate with secondary intention healing. 
Conjunctival surface reconstruction was avoided in order to monitor the surgical site for possible 
recurrence of the tumor. The bulbar conjunctiva healed with a smooth surface, no signs of 
inflammation and no evidence of recurrence 1 year after surgery (fig. 2a). 
Histological examination confirmed the diagnosis of a stage b and c KS, characterized by the 
presence of spindle cells positive on CD31, CD34 and Ulex Europaeus markers with minimal 
pleomorphism and mitotic activity. They are forming slits containing extravasated red blood cells, 
whereas extracellular or intracellular periodic acid-Schiff-positive hyaline bodies can also be found [6] 
(fig. 2b). Histology revealed that the tumor was excised with a clear margin of healthy conjunctival 
tissue with no deep invasion to the underlying tissues. The specimen was also tested negative for HHV-8 
infection by means of polymerase chain reaction (PCR). In view of the special clinical characteristics of 
such a malignancy, the patient was referred to the immunology and infectious diseases department for 
evaluation and subsequent postoperative follow-up of his general health. He was diagnosed 
immunocompetent with normal immunoglobulin levels and no evidence of HIV or other viral 
infection. His immune condition remained unremarkable throughout the observation period of 5 years. 
Discussion 
Ocular KS is rare in HIV-negative patients with less than 30 cases being reported 
before 1982. Only 20% of AIDS patients suffering from KS have ocular manifestations 
(lids or conjunctiva) and in 12% of cases ocular involvement is the primary manifestation 
of systemic disease [7–9]. 
Ocular lesions have slow growth and can be cured with simple surgical excision 
whereas cryotherapy is an adjunctive intervention which was not used in our case because 
of the clear tumor margins and the lack of systemic involvement. Radiotherapy with 
chemotherapy is reserved for multifocal aggressive disease [10–12]. 
Simple complete surgical excision was curative in our case with no evidence of 
recurrence or distant metastasis and no immune-related general health problems in the 
postoperative observation of 5 years. Differential diagnosis of similar lesions should 
include arteriovenous shunt, pyogenic granuloma, malignant blue nevus, bacterial 
angiomatosis and vascular malformations. Isolated KSs of the conjunctiva unrelated to 
AIDS have been reported previously [13]. 
This case may strengthen the evidence that such conjunctival malignancies may occur 
as an isolated incidence and do not necessarily relate to AIDS or immunosuppression 
[14]. Simple surgical excision of the conjunctival lesion, with no adjunctive measure, can 
be curative with no evidence of recurrence or distant metastasis in a long-term follow-up 
of 5 years. Case Rep Ophthalmol 2011;2:193–197 
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Fig. 1. a Solid mass on the superior bulbar conjunctiva displacing the upper eyelid upwards. b CT scan 
imaging of the orbits shows no scleral or orbital extension of the lesion. 
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Fig. 2. a Appearance of the bulbar conjunctiva 12 months after surgery with little visible scar tissue 
and no evidence of recurrence. b Histology section shows the characteristic neoplastic spindle cells 
forming slits filled with extravasated red blood cells. HE, ×200. 
 
References 
1 Verma V, Shen D, Sieving PC, Chan CC: The role of infectious agents in the etiology of ocular adnexal 
neoplasia. Surv Ophthalmol 2008;53:312–331. 
2 Howard GM, Jakobiec FA, DeVoe AG: Kaposi’s sarcoma of the conjunctiva. Am J Ophthalmol 1975;79:420–
423. 
3 Lieberman PH, Llovera IN: Kaposi’s sarcoma of the bulbar conjunctiva. Arch Ophthalmol 1972;88:44–45. 
4 Curtis TH, Durairaj VD: Conjunctival Kaposi sarcoma as the initial presentation of human immunodeficiency 
virus infection. Ophthal Plast Reconstr Surg 2005;21:314–315. 
5 Kurumety UR, Lustbader JM: Kaposi’s sarcoma of the bulbar conjunctiva as an initial clinical manifestation of 
acquired immunodeficiency syndrome. Arch Ophthalmol 1995;113:978. 
6 Weiter JJ, Jakobiec FA, Iwamoto T: The clinical and morphologic characteristics of Kaposi’s sarcomas of the 
conjunctiva. Am J Ophthalmol 1980;89:546–552. 
7 Schmid K, Wild T, Bolz M, Horvat R, Jurecka W, Zehetmayer M: Kaposi’s sarcoma of the conjunctiva leads to 
a diagnosis of acquired immunodeficiency syndrome. Acta Ophthalmol Scand 2003;81:411–413. 
8 Shuler JD, Holland GN, Miles SA, Miller BJ, Grossman I: Kaposi sarcoma of the conjunctiva and eyelids 
associated with the acquired immunodeficiency syndrome. Arch Ophthalmol 1989;107:858–862. 
9 Kalinske M, Leone CR Jr: Kaposi’s sarcoma involving eyelid and conjunctiva. Ann Ophthalmol 1982;14:497–
499. Case Rep Ophthalmol 2011;2:193–197 
DOI: 10.1159/000329541 
Published online: 
June 14, 2011 
© 2011 S. Karger AG, Basel
ISSN 1663–2699 





10 Kirova YM, Belembaogo E, Frikha H, Haddad E, Calitchi E, Levy E, Piedbois P, Le Bourgeois JP: Radiotherapy 
in the management of epidemic Kaposi’s sarcoma: a retrospective study of 643 cases. Radiother Oncol 
1998;46:19–22. 
11 Ghabrial R, Quivey JM, Dunn JP Jr, Char DH: Radiation therapy of acquired immunodeficiency syndrome-
related Kaposi’s sarcoma of the eyelids and conjunctiva. Arch Ophthalmol 1992;110:1423–1426. 
12 Dugel PU, Gill PS, Frangieh GT, Rao NA: Treatment of ocular adnexal Kaposi’s sarcoma in acquired immune 
deficiency syndrome. Ophthalmology 1992;99:1127–1132. 
13 Ron IG, Kremer I, Lowenstein A, Chaitchik S: Conjunctival involvement in classic (indolent) HIV negative 
Kaposi’s sarcoma. Br J Ophthalmol 1994;78:488–489. 
14 Reiser BJ, Mok A, Kukes G, Kim JW: Non-AIDS-related Kaposi sarcoma involving the tarsal conjunctiva and 
eyelid margin. Arch Ophthalmol 2007;125:838–840. 
 
 
This case report was first presented at the 20th meeting of the European Society of Ophthalmic Plastic 
and Reconstructive Surgery (ESOPRS), Munster, Germany, September 2002. 